Viewing Study NCT00343356


Ignite Creation Date: 2025-12-24 @ 11:36 PM
Ignite Modification Date: 2025-12-25 @ 9:26 PM
Study NCT ID: NCT00343356
Status: COMPLETED
Last Update Posted: 2006-06-22
First Post: 2006-06-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Intravesical Epirubicin Plus BCG to Prevent the Recurrence of Transitional Cell Carcinoma of Bladder
Sponsor: LanZhou University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module